Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers 'a major step' closer to river blindness vaccine
Blackfly
River blindness is spread by blackflies that breed in rivers.

Disease affects around 17 million people worldwide

Researchers have taken a major step towards developing the world's first vaccine against river blindness.

Scientists at the University of Edinburgh say that a vaccination would end a 30 year quest to beat the disease, which affects around 17 million people across the globe.

Over 90 per cent of cases of river blindness occur in west and central Africa.  The disease is caused by infection with the parasitic worm Onchocerca volvulus and is spread by blackflies that breed in rivers.

Around 10 per cent of those infected go on to develop eye conditions, one per cent become blind, and 70 per cent develop very severe skin diseases which can lead to social exclusion.  

Current control of river blindness relies on mass distribution of a drug called ivermectin, which has been successful in reducing incidence of the condition wherever it has been used. However, children under five - who comprise up to 20 per cent of the population in endemic regions - are excluded from the treatment.

Now, scientists from the University of Edinburgh's Division of Infection and Pathway Medicine have identified three potential vaccine compounds the could offer protection against the disease.

They hope to take at least one of these potential vaccines to safety trials, and to test its effectiveness by 2025.  Eventually they hope to administer a vaccine to children as part of national immunisation programmes.

Commenting on the study, lead researcher professor David W Taylor, said: "New knowledge of the way nematode parasites regulate people's immune responses has guided formulation of experimental vaccines.

"A vaccine for river blindness would compliment and augment existing treatment and significantly improve the prospects for eliminating this disease from Africa."

The research initiative - The Onchocerciasis Vaccine for Africa (TOVA) - was launched in response to the London Declaration on Neglected Tropical Diseases which called for tools to eliminate river blinds from Africa.

TOVA builds on over 30 years of research by Academics from Edinburgh and researchers in Africa, Europe, and the US and involves 15 organisations across five countries.

Image (C) Wikimedia commons

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.